Cancer Research Technology
Log in Register
Menu

HR1 Cell Line

Invented by Dr Simon Cook at Babraham Institute

Info

Catalogue Number 153329
Antigen/Gene or Protein Targets c-Raf1
Parental Line HEK 293
Synonyms RAF proto-oncogene serine/threonine-protein kinase (EC:2.7.11.1), Proto-oncogene c-RAF, cRaf, Raf-1
Host Human
Tissue Kidney
Disease Keywords Cell signalling pathways; cancer; inflammation
Relevance HR1 cells are HEK 293 cells stably expressing conditional kinase ∆Raf-1:ER* from the pCMV Neo Myc plasmid. ∆Raf-1:ER* (also known as ∆CRAF:ER*) consists of the isolated kinase domain of c-Raf1 fused in-frame to a modified form of the hormone binding domain of the estrogen receptor (hbER*) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not β-estradiol. In this case the * refers to a point mutation that ablates estradiol binding but allows 4-HT binding.

Activation of ∆Raf-1:ER* leads to the selective activation of the ERK1/2 pathway. This cell line can be used to study the cellular role and factors impacting on the ERK1/2 signalling pathway such as gene expression, cell proliferation, cell cycle arrest and cell death. The cells are G418 resistant. Conditional kinase activation of ∆Raf-1:ER* can be induced with 100nM 4-HT.
Production Details HEK 293 cells were transfected with the pCMV Neo Myc plasmid expressing ∆Raf-1:ER*. Stable transfectants were selected by neomycin resistance using G418 (Geneticin) and ring cloning.
Conditional Yes
Conditional Description Stable transfectant, conditional functionality: c-Raf1 kinase activity and ERK1/2 signalling pathway activated following 4-hydroxytamoxifen (4-HT) treatment of cells.
Research Area Apoptosis and Programmed Cell Death, Cancer, Cell Cycle, Cell Signaling & Signal Transduction, Immunology
Growth/Phenotype Keywords Adherent cell line
Recommended Growing Conditions Phenol red-free Dulbecco’s modified Eagle’s medium (DMEM) high glucose version, 2 mM L-glutamine, 10% fetal bovine serum (FBS), 400 µg/ml G418 (Geneticin).
Cellosaurus ID CVCL_2676

References

There are 8 reference entries for this reagent.

View All References

References: 8 entries

Gilley et al. 2009. Cell Signal. 21(6):969-77. PMID: 19249353.

ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.

Europe PMC ID: 19249353

Wiggins et al. 2007. Cell Signal. 19(12):2605-11. PMID: 17884340.

c-Cbl is not required for ERK1/2-dependent degradation of BimEL.

Europe PMC ID: 17884340

Ewings et al. 2007. EMBO J. 26(12):2856-67. PMID: 17525735.

ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.

Europe PMC ID: 17525735

Boughan et al. 2006. J Biol Chem. 281(17):11637-48. PMID: 16513653.

Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.

Europe PMC ID: 16513653


Add a reference

References: 8 entries

Gilley et al. 2009. Cell Signal. 21(6):969-77. PMID: 19249353.

ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.

Wiggins et al. 2007. Cell Signal. 19(12):2605-11. PMID: 17884340.

c-Cbl is not required for ERK1/2-dependent degradation of BimEL.

Ewings et al. 2007. EMBO J. 26(12):2856-67. PMID: 17525735.

ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.

Boughan et al. 2006. J Biol Chem. 281(17):11637-48. PMID: 16513653.

Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.


Add a reference